On December 18, 2025, GSK plc purchased 235,000 shares at an average price of 1,810.34p as part of its ongoing buyback program, which has totaled 14,321,733 shares since September 30, 2025. Following this transaction, GSK holds 239,786,577 shares in treasury and has 4,075,654,506 shares in issue, maintaining 5.88% of voting rights in treasury.